Heleen H DeCory Selected Research

Suspensions

1/2021	Characterization of Polybacterial versus Monobacterial Conjunctivitis Infections in Pediatric Subjects Across Multiple Studies and Microbiological Outcomes with Besifloxacin Ophthalmic Suspension 0.6.
1/2020	Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6.
4/2017	Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis.
3/2017	Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates.
1/2015	Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heleen H DeCory Research Topics

Disease

3	Infections 01/2021 - 01/2020
3	Bacterial Conjunctivitis 01/2021 - 03/2017
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2006 - 03/2004
2	Conjunctivitis 01/2021 - 01/2020
2	Eye Infections 01/2020 - 01/2018
2	Cataract (Cataracts) 01/2019 - 01/2015
1	Pain (Aches) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2018
1	Ocular Hypertension (Glaucoma, Suspect) 01/2018
1	Blepharitis 04/2017
1	Hyperemia 03/2017

Drug/Important Bio-Agent (IBA)

5	SuspensionsIBA 01/2021 - 01/2015
5	besifloxacin FDA Link 01/2021 - 01/2015
3	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 01/2015
3	Methylphenidate (Ritalin)FDA LinkGeneric 12/2006 - 03/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
2	CoagulaseIBA 01/2020 - 01/2018
2	Loteprednol Etabonate (Alrex)FDA Link 01/2019 - 04/2017
1	FluoroquinolonesIBA 01/2021
1	BOL 303259-XIBA 01/2018
1	Tobramycin (Nebcin)FDA LinkGeneric 04/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2017
1	Gatifloxacin (Zymar)FDA Link 03/2017
1	Moxifloxacin (Avelox)FDA Link 01/2015

Therapy/Procedure

1	Therapeutics 01/2021
1	Intraocular Lens Implantation 01/2019
1	Ambulatory Care (Outpatient Care) 03/2017